236 results
Page 3 of 12
8-K
h4cyp6bga5 38sj1v0
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
8-K
EX-99.3
d3rkm2g
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
8-K
EX-99.2
q6wr636
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
424B3
t0etsgx dhxyhjy60s
10 Nov 22
Prospectus supplement
4:21pm
425
mfzgh
27 Oct 22
Business combination disclosure
7:15am
8-K
EX-99.1
ioiwlrpzd 32drvn
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
8-K
70cs76q6x6l
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
425
8h5sd 9yj4szpi55t
26 Oct 22
Business combination disclosure
5:17pm
8-K
w39 zczrwh0pp16eo
26 Oct 22
Regulation FD Disclosure
5:14pm
8-K
EX-99.1
jlksm 93u6foo5ot4bi
26 Oct 22
Regulation FD Disclosure
5:14pm
425
mf9dvyu8j
26 Oct 22
Business combination disclosure
5:10pm
8-K
6opokvt9at29aqms1w
26 Oct 22
Regulation FD Disclosure
5:08pm
8-K
EX-99.1
zfyhrlbk
26 Oct 22
Regulation FD Disclosure
5:08pm
425
srle6f pnh1nmhtygd
24 Oct 22
Business combination disclosure
8:00am
8-K
gx4xhi9
24 Oct 22
Entry into a Material Definitive Agreement
7:59am
425
vdlta21z ty2
17 Oct 22
Business combination disclosure
4:03pm
8-K
EX-99.1
9t486x500ntphkc1
17 Oct 22
Clinical trial anticipated to begin in late 2022
4:02pm